Open AccessPrevalence of FVIII Inhibitors Among Children with Hemophilia A: Experience at the Jordanian Royal Medical Services
Author(s) -
Raida Oudat,
Muna Al-Maharmeh,
Rasha Al-Ghrayeb,
Tunia Ogeilat,
Maher Mustafa
Publication year - 2020
Publication title -
medicinski arhiv
Language(s) - English
Resource type - Journals
eISSN - 1986-5961
pISSN - 0350-199X
DOI - 10.5455/medarh.2020.74.187-190
Subject(s) - medicine , titer , incidence (geometry) , coagulation , antibody , complication , disease , gastroenterology , immunology , pediatrics , physics , optics
Replacement therapy is constantly required by Hemophilia A (HA) patients lacking coagulation factor VIII (FVIII). The most serious complication of this treatment is the development of neutralizing antibodies (inhibitors).